IEM Weekly Newsletter
September 20, 2022
View this email in your browser.
In This Newsletter


OPALs, The Shimmering Next Generation

This summer, IEM launched the Outreach Program for Advancing Learning in STEM (OPALS) in transition from the Biophotonics Outreach Program. Dr. Linda Shi spearheads the six week program for pre-college students to gain hands-on experience in a research laboratory environment.

Read More


MARC Southern California RheumTalk Seminar Series

Thursdays at 12PM PST
Zoom Link:

Thursday Sept 22nd, 12PM-1PM
Cryopyrin: The coolest inflammasome
Harold Hoffman, Professor of Pediatrics & Medicine, Division Chief of RAI Department of Pediatrics at UC San Diego/Rady Children’s Hospital.

Learn More
Fall Seminar Series 2022

Sponsored by The Department of Bioengineering and the Institute of Engineering in Medicine (IEM).
Fridays, 2-3PM PST - FUNG Auditorium/PFBH
Faculty Host: Brian Aguado, Ph.D.

Friday, September 23, 2022
Tatiana Segura, Ph.D
Modulating immune responses with MAP scaffolds

Click here for more information and a list of upcoming seminars
4DN Tutorial Series

Friday, September 23rd, 2022

Zoom Link:

The 4D Nucleome Network aims to understand the principles underlying nuclear organization in space and time, the role nuclear organization plays in gene expression and cellular function, and how changes in nuclear organization affect normal development as well as various diseases. The 4DN data portal hosts a variety of data generated from sequencing and imaging-based assays, with an emphasis on data from chromatin conformation capture (CCC) techniques and more recently multiplexed FISH imaging experiments.

Nucleate San Diego: Meet Activator Alumni and Learn about Nucleate

Wednesday, September 28, 3PM PST

Want to learn more about Nucleate? Hear from their alumni founders on their challenges, successes, and how Activator helped them get started (+tips for applying). They will be joined by some of the founders of Manifold Bio, CacheDNA, Gammunity, InGel Therapeutics, and Kano Therapeutics. Register now at

To learn more about Nucleate and their various opportunities and upcoming events, visit their website.

FUNDING & GRANT OPPORTUNITIES Prize for Ideas in Cell-Cell Communication

New Prize opportunity for early-career scientists interested in the study of cell-cell communication. The prize will include an award of $5,000 US and recognition will be given to all worthy submissions. Students and postdocs from any institution worldwide are welcome to apply. By submitting your ideas, you will join a global network of innovative, well-known senior scientists and contribute to an effort that will shape future research in this important field.

The deadline to submit is Friday, September 30, 2022.

Learn More
Connect With Us!

Want to follow IEM for more news and updates?

Check out our social media! 
We're on Twitter, LinkedIn, and Instagram. Never miss an update from IEM and get news on the latest seminars, awards, and stories from our members and centers.

Twitter: @ucsd_iem
LinkedIn: UC San Diego IEM
In an effort to promote all updates and the success of our various Centers, IEM would like to hear your stories. Submit any news, updates, stories regarding your center or research and we will publicize the content across all IEM media outlets!

Click the button below to submit a Google Form and let us know about any opportunities or information you have to share. We will take care of the rest!
Submit an Update
Learn more about IEM and connect with our Research Centers:
Biomaterials and Tissue Engineering Center | Center for Musculoskeletal Research
Center for Advanced Neurological Engineering | Whitaker Center for Biomedical Engineering | Cardiac Biomedical Science and Engineering Center | Center for Medical Device Engineering and Biomechanics | Center for Engineering in Cancer | Center for Mobile-health Systems and Applications | Infectious Disease Engineering Advances

Contact Us:
Department Email:

Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.